NHERF1 and neoplasm of oropharynx: Collectively, our data support a model whereby the level and subcellular distribution of EBP50 may determine its function, define distinct patient profiles and identify loss of EBP50 as a potential surrogate biomarker for HR-HPV infection in oropharyngeal tumours (Fig. 3).